Skip to main content

Table 3 HR for total mortality according to quintiles of total polyphenol intake (stratified by risk factors)

From: Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial

Risk factor

No. of deaths

No. of person-years

Multivariable-adjusted HR (95% CI), Quintile 5 vs. 1*

P-trend

P-interaction

Sex

     

Men

203

13,317

0.76 (0.46 to 1.26)

0.23

0.39

Women

124

17,751

0.42 (0.18 to 0.98)

0.24

 

Age, y

     

<70

142

21,483

0.58 (0.31 to 1.08)

0.21

0.73

≥70

185

9,585

0.70 (0.39 to 1.24)

0.34

 

Alcohol intake

     

Nondrinkers

133

12,510

0.39 (0.17 to 0.90)

0.04

0.16

Drinkers

194

18,558

0.99 (0.59 to 1.65)

0.91

 

Smoking

     

Never

144

19,520

0.64 (0.31 to 1.32)

0.47

0.93

Former

111

7,465

0.52 (0.25 to 1.07)

0.29

 

Current

72

4,083

0.71 (0.29 to 1.75)

0.21

 

Physical activity

     

Less than median

203

16,224

0.57 (0.32 to 1.02)

0.17

0.43

More than median

124

14,844

0.77 (0.41 to 1.44)

0.73

 

Hypertension

     

Yes

184

12,080

0.63 (0.36 to 1.10)

0.24

0.21

No

134

17,721

0.82 (0.44 to 1.55)

0.76

 

Diabetes mellitus

     

Yes

205

15,345

0.79 (0.47 to 1.33)

0.92

0.52

No

122

15,723

0.60 (0.31 to 1.17)

0.09

 

Intervention group

     

MedDiet-EVOO

113

11,478

0.67 (0.31 to 1.46)

0.68

0.71

MedDiet-Nuts

108

10,134

0.68 (0.34 to 1.35)

0.81

 

Control Diet

106

9,456

0.48 (0.23 to 0.98)

0.01

 
  1. HR, Hazard ratio; CI, Confidence interval; MedDiet-EVOO, Mediterranean Diet supplemented with extra virgin olive oil; MedDiet-nuts, Mediterranean Diet supplemented with nuts.
  2. *The multivariable HR has been additionally adjusted for age (<60, 60to 4.9, 65 to 69.9, 70 to 74.9, >/=75 years), smoking (never, past and current: cigarettes (<5, 5 to 19, >20 per day) or cigars and pipes (<3, 3 to 6, >6 per day)), BMI (<25, 25 to 29.9, or >/=30 Kg/m2), baseline diabetes, alcohol (0, 0.1 to 14.9, 15 to 29.9, >/=30 g/day), total energy intake (continuous variable), physical activity (continuous variable), family history of CVD or cancer, aspirin use, antihypertensive drug use, use of cardiovascular medication, use of oral hypoglycemic agents, insulin, other medication. Analyses were stratified by sex, recruitment center and intervention group.